|
GB202102694D0
|
|
Use of cannabidiol and clobazam in the treatment of childhood-onset epilepsy syndromes
|
|
GB202102010D0
|
|
Use of cannabidivarin in the treatment of seizures associated with canine epilepsy
|
|
GB202020274D0
|
|
Identification and treatment of patients with epilepsy
|
|
GB202019787D0
|
|
A method for evaluating the pro- or anti convulsive properties of test compounds
|
|
GB202019786D0
|
|
Novel compounds, methods for their manufacture, and uses thereof
|
|
GB202019784D0
|
|
Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof
|
|
GB202019301D0
|
|
Use of cannabidiol in the treatment of seizures associated with epilepsy syndromes
|
|
GB202014723D0
|
|
Use of cannabinoids in the treatment of epilepsy
|
|
GB202014250D0
|
|
Use of cannabidivarin in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB202013765D0
|
|
Method of preparing cannabinoids
|
|
GB202011156D0
|
|
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB202011159D0
|
|
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB202011164D0
|
|
Use of cannabidiol in the treatment of seizures associated with rare epilepsy sydromes related to genetic abnormalities
|
|
GB202011173D0
|
|
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB202011151D0
|
|
Use of cannabidiol in the treatment of seizures associated with shaken baby syndrome
|
|
GB202011127D0
|
|
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB202011155D0
|
|
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
|
|
GB202011163D0
|
|
Use of cannabidiol in the treatment of seizures associated with rare epliepsy syndromes related to genetic abnormalites
|
|
GB202011119D0
|
|
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
|
|
GB202011158D0
|
|
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
